Therapeutic Classification: anti irritable bowel syndrome agents
Pharmacologic Classification: calcium channel blockers
REMS
Absorption: Poorly absorbed (110%).
Distribution: Distributes selectively to digestive tract.
Protein Binding: 97%.
Half-Life: 1.5 hr.
Contraindicated in:
Use Cautiously in:
All less than 1%
GI: constipation, diarrhea, distention, dry mouth, epigastric pain/fullness, esophageal irritation, nausea
Derm: rash
Drug-drug: